Diabetes Clinical Trials in Minneapolis

Showing 101-120 of 472 trials

Hybrid Closed Loop Therapy and Verapamil for Beta Cell Preservation in New Onset Type 1 Diabetes (CLVer): Extension Study

NCT06177691

The purpose of this extension study is to continue to follow the participants who completed the CLVer RCT for up to 3 additional years. The goal for Cohort A is to evaluate the longer-term effects of verapamil on preservation of β-cell function as measured by C-peptide levels obtained during a mixed meal tolerance test (MMTT). For both Cohorts A and B, the goal is to determine if the high degree of glycemic control achieved during CLVer with HCL can be maintained once the intensive engagement of the study team is discontinued. At the completion of the RCT, study treatments end. Thus, during the extension study, diabetes management is performed as part of usual care and there is no study treatment.

Type1 Diabetes

Jaeb Center for Health Research77 participantsStarted May 2021

Palo Alto, California, United States • Aurora, Colorado, United States • New Haven, Connecticut, United States +3 more locations

COMPLETEDNA< 1 mile

Look AHEAD: Action for Health in Diabetes

NCT00017953

The Look AHEAD study is a multi-center, randomized clinical trial to examine the long-term effects of a lifestyle intervention designed to achieve and maintain weight loss. The study will investigate the effects of the intervention on heart attacks, stroke and cardiovascular-related death in individuals with type 2 diabetes who are also overweight or obese.

DiabetesMyocardial InfarctionStroke+3 more

Wake Forest University Health Sciences5,145 participantsStarted Jun 2001

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Los Angeles, California, United States +15 more locations

Hybrid Closed Loop Therapy and Verapamil for Beta Cell Preservation in New Onset Type 1 Diabetes (CLVer): Extension Study

Look AHEAD: Action for Health in Diabetes

Diabetes Trials in Other Cities

Measurement of Glucose Metabolism in Humans: Effect of Recurrent Hypoglycemia on Hypothalamic GABA

Intra-nasal Naloxone for Treatment of Impaired Awareness of Hypoglycemia

A Study to Assess the Safety and Tolerability of Different Doses of AG019 Administered Alone or in Combination With Teplizumab in Participants With Recent-onset Diagnosed Type 1 Diabetes (T1D)

Managing Diabetes Mindfully Study

Family Health History in Diverse Care Settings (FHH)

Effect of Sotagliflozin on Cardiovascular Events in Participants With Type 2 Diabetes Post Worsening Heart Failure (SOLOIST-WHF Trial)

A Study to Test Whether Different Doses of BI 456906 Are Effective in Treating Adults With Type 2 Diabetes.

A Phase 2 Study of LY3209590 in Participants With Type 2 Diabetes Mellitus

A Study to Evaluate THR-687 Treatment for Diabetic Macular Oedema.

A Research Study to Compare Two Doses of Semaglutide Taken Once Weekly in People With Type 2 Diabetes

Efficacy and Safety of Oral Semaglutide Versus Liraglutide and Versus Placebo in Subjects With Type 2 Diabetes Mellitus

RISE Adult Medication Study

The Effect of In-utero Exposure to Metformin in 5-11 Year Old Offspring of Mothers in the MiTy Trial

An Extension Trial of Inclisiran in Participants With Cardiovascular Disease and High Cholesterol

An add-on Study to the FIGARO-DKD Study Called FIGARO-BM to Learn About the Link Between Biomarkers (Substances in the Blood Used as Indicators of Biological Processes, Disease Processes or Responses to Medication) and Finerenone in FIGARO-DKD Participants

Impact of Acetaminophen on Performance of Guardian™ Sensor (3) in Adults

Evaluation of Updated Continuous Glucose Monitoring (CGM) Form Factor in Adults, Adolescents and Pediatrics

Study to Determine the Efficacy, Safety, Tolerability & Pharmacokinetics of RO 205-2349 in Patients With Type 2 Diabetes Mellitus

Other Conditions in Minneapolis